PDR Update
- Labeling Updates as of May 1, 2023 - Issue 3
- Drug Updates
Labeling Updates as of May 1, 2023 - Issue 3
- Key
-
Boxed Warning
-
Other Warnings*
*Warnings and Precautions; Adverse Reactions; Drug Interactions; and Contraindications
-
Updates to Indications/Dosage
-
Other Updates†
†Other labeling changes; added to PDR database
No Avycaz boxed warning |
![]() |
No Avycaz Indications/Dosage Updates |
![]() |
Avycaz (avibactam/ceftazidime) |
No Brukinsa boxed warning | No Brukinsa Other Warnings | No Brukinsa Indications/Dosage Updates |
![]() |
Brukinsa (zanubrutinib) |
No Depakote ER boxed warning | No Depakote ER Other Warnings |
![]() |
![]() |
Depakote ER (divalproex sodium) |
No Depakote Sprinkle Capsules boxed warning |
![]() |
![]() |
![]() |
Depakote Sprinkle Capsules (divalproex sodium) |
No Depakote Tablets boxed warning |
![]() |
![]() |
![]() |
Depakote Tablets (divalproex sodium) |
No Liletta SHI boxed warning |
![]() |
No Liletta SHI Indications/Dosage Updates |
![]() |
Liletta SHI (levonorgestrel) |
No Lo Loestrin Fe boxed warning | No Lo Loestrin Fe Other Warnings | No Lo Loestrin Fe Indications/Dosage Updates |
![]() |
Lo Loestrin Fe (ethinyl estradiol/ferrous fumarate/norethindrone acetate) |
No Ozurdex boxed warning | No Ozurdex Other Warnings | No Ozurdex Indications/Dosage Updates |
![]() |
Ozurdex (dexamethasone) |
No Rinvoq boxed warning |
![]() |
![]() |
![]() |
Rinvoq(upadacitinib) |
No Skyrizi boxed warning | No Skyrizi Other Warnings |
![]() |
![]() |
Skyrizi (risankizumab-rzaa) |
No Synthroid boxed warning |
![]() |
![]() |
![]() |
Synthroid (levothyroxine sodium) |
No Ubrelvy boxed warning |
![]() |
No Ubrelvy Indications/Dosage Updates |
![]() |
Ubrelvy (ubrogepant) |
No Verquvo boxed warning | No Verquvo Other Warnings | No Verquvo Indications/Dosage Updates |
![]() |
Verquvo (vericiguat) |
No Vraylar boxed warning |
![]() |
![]() |
![]() |
Vraylar (cariprazine) |
No Vuity boxed warning |
![]() |
![]() |
![]() |
Vuity (pilocarpine hydrochloride) |
Drug Updates
Get more information on PDR's monthly Drug Updates, including the latest in FDA news.